Investigational Gel Very Effective Against Cutaneous T-Cell Lymphoma Lesions

A conference abstract suggests a possible new treatment for lesions caused by cutaneous T-cell lymphoma.

Alain H. Rook, M.D., of the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, and colleagues presented an abstract at the annual meeting of the American Academy of Dermatology meeting demonstrating that the investigational drug resiquimod successfully healed cutaneous T-cell lymphoma lesions in a small peer-supported trial.

This phase I open-label clinical trial had 10 patients with recurrent or treatment refractory cutaneous T-cell lymphoma lesions who had tried anywhere from two to 10 medications unsuccessfully. However, all experienced lesion healing with a low incidence of side effects from 0.03 percent topical resiquimod gel.

Toll-like receptors 7 and 8 – proteins beneath the skin involved with immune system activation – were both triggered by the investigational drug.

"It's been very trying to get this study going," Rook said. "It took us eight years. We were required to have 100 percent of the funding to get this particular study going, and only then were we able to acquire [resiquimod], not from the North American company, but from the European company. What we know now is that resiquimod is a dual TLR 7/8 agonist, its bioavailability is 10 times that of imiquimod, and its potency in vitro is up to 100 times that of imiquimod."

He went on to say that only four or five small lesions were treated during the study but that even lesions outside the treatment area appeared to regress. One patient hadn't been in clinical remission for 15 years, yet this patient's lesions were completely healed at week 24 of the study.

Drug well-tolerated, easy to apply

Resiquimod was formulated about 15 years ago. It has previously been tested unsuccessfully as a topical treatment for genital herpes.

"There are numerous potential indications with this drug," added Rook. "There's no question in my mind that it will be far more effective than imiquimod in – well, you name it – basal cells, squamous cells, Kaposi sarcoma, and infectious disorders of the skin."

Source: Medpage Today

More Articles

More Articles

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

Is there such a thing as an average cost of chemotherapy? No. Not even close. In order for there to be an average cost of chemotherapy, one would...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...

This entry looks at one of those types of lymphoma sometimes referred to simply as abdominal lymphoma. 'Lymphoma' is an umbrella term that...

Usually, even if a subtype of lymphoma is known to be indolent (slow-growing), it is considered a malignant...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma diagnosis is not difficult to determine once a patient and doctor begin to look for signs of cancer...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Hodgkin's Lymphoma a.k.a. Hodgkin's Disease is a malignant (cancerous) growth of cells in the lymphatic system...

Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many cells and organs, including the lymph nodes, thymus...